NRO 📈 Neurones - Overview
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0004050250
NRO: Infrastructure, Application, Consulting, Cloud, Cybersecurity, Automation, IT
Neurones S.A., an information technology (IT) services company, provides infrastructure, application, and consulting services in France and internationally. Its infrastructure services include infrastructure management, manages public and private cloud services, IT operations, user support, DevOps, cybersecurity, IT service management, information system governance, and automation. The company also provides application services in the areas of SAP, digital, WEB, mobility, UX/UI, enterprise content and document management, business process management, robotic process automation, dematerialization, IT consulting for finance, big data, and DevOps, IT training and change management, and Innovation connected devices (IOT). In addition, it offers consulting services, including management and digital transformation, and digital marketing consulting; digital transformation services in the areas of agile/scrum, DevOps, CI/CD, cloud, infrastructure as code, cyber security, analytics, big data, mobility, digital workplace, connected devices, innovations, client experience, UX/UI, and digital marketing, as well as internal process digitization, ECM/BPM, RPA, dematerialization, AI, predictive maintenance, machine learning, and blockchain; and managed services/outsourcing services. The company serves banking/insurance, services/consumer goods, energy/utilities/healthcare, technologies/media/telecoms, industry/public works and civil engineering, and public sector markets. Neurones S.A. was founded in 1984 and is based in Nanterre, France. Web URL: https://www.neurones.net
Additional Sources for NRO Stock
NRO Stock Overview
| Market Cap in USD | 1,122m |
| Sector | Technology |
| Industry | Information Technology Services |
| GiC Sub-Industry | IT Consulting & Other Services |
| IPO / Inception |
NRO Stock Ratings
| Growth 5y | 86.4% |
| Fundamental | 69.8% |
| Dividend | 60.0% |
| Rel. Strength Industry | -98.5 |
| Analysts | - |
| Fair Price Momentum | 47.25 EUR |
| Fair Price DCF | 68.23 EUR |
NRO Dividends
| Dividend Yield 12m | 2.74% |
| Yield on Cost 5y | 6.81% |
| Annual Growth 5y | 78.92% |
| Payout Consistency | 88.7% |
NRO Growth Ratios
| Growth Correlation 3m | -9.8% |
| Growth Correlation 12m | 22.5% |
| Growth Correlation 5y | 96.4% |
| CAGR 5y | 19.39% |
| CAGR/Mean DD 5y | 2.90 |
| Sharpe Ratio 12m | 0.07 |
| Alpha | -11.95 |
| Beta | 0.53 |
| Volatility | 22.24% |
| Current Volume | 1.3k |
| Average Volume 20d | 6.6k |
What is the price of NRO stocks?
As of December 21, 2024, the stock is trading at EUR 43.60 with a total of 1,325 shares traded.
Over the past week, the price has changed by +0.34%, over one month by -3.74%, over three months by +2.94% and over the past year by +0.32%.
As of December 21, 2024, the stock is trading at EUR 43.60 with a total of 1,325 shares traded.
Over the past week, the price has changed by +0.34%, over one month by -3.74%, over three months by +2.94% and over the past year by +0.32%.
Is Neurones a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Neurones (PA:NRO) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 69.82 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NRO as of December 2024 is 47.25. This means that NRO is currently overvalued and has a potential downside of 8.37%.
Yes, based on ValueRay Fundamental Analyses, Neurones (PA:NRO) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 69.82 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NRO as of December 2024 is 47.25. This means that NRO is currently overvalued and has a potential downside of 8.37%.
Is NRO a buy, sell or hold?
Neurones has no consensus analysts rating.
Neurones has no consensus analysts rating.
What are the forecast for NRO stock price target?
According to ValueRays Forecast Model, NRO Neurones will be worth about 51.7 in December 2025. The stock is currently trading at 43.60. This means that the stock has a potential upside of +18.6%.
According to ValueRays Forecast Model, NRO Neurones will be worth about 51.7 in December 2025. The stock is currently trading at 43.60. This means that the stock has a potential upside of +18.6%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 50 | 14.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 51.7 | 18.6% |